Oligoclonal expansion and loss of cytotoxic functionality of CAR-T cells in a DLBCL patient after CD19.CAR-T cell therapy

被引:0
|
作者
Mueller, F. [1 ,2 ]
Schwingen, N. R. [1 ]
Eisenhauer, N. [1 ]
Aigner, M. [1 ,2 ]
Schletter, M. [1 ]
Lutzny-Geier, G. [1 ]
Lischer, C. [3 ]
Guese, E. [1 ]
Gebhard, C. [4 ]
Rehli, M. [4 ,5 ]
Gonzalez, Vera J. [3 ]
Eckstein, M. [6 ]
Wiesmueller, M. [7 ]
Erber, R. [6 ]
Bruns, H. [1 ,2 ]
Mackensen, A. [1 ,2 ]
Voelkl, S. [1 ,2 ]
机构
[1] Univ Hosp Erlangen, Dept Internal Med Hematol & Oncol 5, Erlangen, Germany
[2] Bavarian Ctr Canc Res BZKF, Partner Site Erlangen, Erlangen, Germany
[3] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany
[4] Leibniz Inst Immunotherapy, Regensburg, Germany
[5] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany
[6] Univ Hosp Erlangen, Inst Pathol, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany
[7] Univ Hosp Erlangen, Dept Radiol, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V504
引用
收藏
页码:73 / 74
页数:2
相关论文
共 50 条
  • [31] Secondary malignancies after CAR-T cell therapy
    Lorenz, Judith
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (22) : 1312 - 1313
  • [32] Ischemic Stroke After CAR-T Cell Therapy
    Shah, Varun
    Jazebi, Noushin
    Chen, Merry
    NEUROLOGY, 2019, 92 (15)
  • [33] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [34] CAR-T cells, the first pharmaceutical cell therapy
    Laurence, Arian
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (05)
  • [35] Relapses After CAR-T Therapy
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (18): : 1850 - 1850
  • [36] Beyond CD19 CAR-T cells in lymphoma
    Leung, Wingchi K.
    Ayanambakkam, Adanma
    Heslop, Helen E.
    Hill, LaQuisa C.
    CURRENT OPINION IN IMMUNOLOGY, 2022, 74 : 46 - 52
  • [37] Toxicities of CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Turtle, Cameron J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S42 - S49
  • [38] ROLE OF CAR-T CELLS THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Sen, P.
    Saadeh, B.
    Loh, E.
    VALUE IN HEALTH, 2019, 22 : S440 - S441
  • [39] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
  • [40] CAR-T Cell Therapy and Beyond
    Dotti, Gianpietro
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4